Friday, Jul 12, 2024 | Last Update : 07:34 PM IST

Covaxin Page-2

Expert Committee recommends Covaxin for children, DCGI nod awaited

The vaccine manufacturer had completed the Phase 2/3 trials of Covaxin for use in children under 18 years of age in mid-September

12 Oct 2021 1:42 PM

WHO to decide on Bharat Biotech's Covaxin emergency usage in October

The duration of the emergency use listing process depends on the quality of the data which is submitted by the vaccine manufacturer

30 Sep 2021 1:22 PM

WHO's emergency use authorisation for Covaxin further delayed: Sources

The Strategic Advisory Group of Expert on Immunization (SAGE) will be meeting on October 5 on EUA to Covaxin

28 Sep 2021 2:07 PM

Bharat Biotech completes phase 2/3 trials of Covaxin for children under 18 years

On the production levels of Covaxin, Ella said 100 million doses per month can be possible

21 Sep 2021 2:24 PM

WHO Experts' Group to take a call on EUL for Covaxin on October 6

Bharat Biotech is expected to give a presentation on the Vaccine's safety and efficacy data of clinical trials

19 Sep 2021 10:55 AM

ADVERTISEMENT

Bharat Biotech awaits feedback from WHO for Covaxin EUL

Rolling data allows the WHO to start its review right away, as information continues to come in, to accelerate the overall review process

17 Sep 2021 2:31 PM

'Number of people who got at least one dose of COVID jab in India highest in world'

Presently, about 60.7 per cent of the adult population in the country has received at least one dose of COVID-19 vaccine, the ministry said

15 Sep 2021 10:48 AM

How tech can help India reach vaccine goals and slow down its COVID-19 disaster

India’s vaccine chain has to protect against contamination before vaccines arrive, using tamper-proof seals and a transparent supply chain

30 Aug 2021 9:57 PM

India logs 45,083 new COVID-19 cases

The death toll has climbed to 4,37,830 with 460 fresh fatalities

29 Aug 2021 10:17 AM

ICMR study in Chennai shows vaccination reduces mortality due to Delta variant

The prevalence of the Delta variant or B.1.617.2 was not different between the vaccinated and un-vaccinated groups

19 Aug 2021 1:00 PM

ADVERTISEMENT

ICMR: Cocktail of Covaxin, Covishield is ‘safe, better’

The study was done by ICMR on 18 individuals who were inadvertently given a shot of Covaxin after their first dose of the Covishield in UP

09 Aug 2021 12:41 AM

Johnson & Johnson's single-dose COVID-19 vaccine gets Emergency Use approval in India

The 5 vaccines granted EUA in India are SI's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson

07 Aug 2021 2:37 PM

After suspending EUA request, Brazil now shelves import authorisation of Covaxin

Bharat Biotech will continue to work diligently with Anvisa, to complete the regulatory approval process for Covaxin

29 Jul 2021 12:13 PM

Brazil scraps Covaxin's EUA application after Bharat Biotech terminates pact

Termination of the MoU came after the deal with the Brazilian Government for supply of 20 million doses of Covaxin landed in controversy

27 Jul 2021 10:28 AM

Second dose trial of Covaxin on 2-6 years to begin by next week

According to sources, children in the above-mentioned age group have already received the first dose of the vaccine

23 Jul 2021 9:52 AM

ADVERTISEMENT

WHO assessing Covaxin data for EUL; Decision date 'to be confirmed'

Rolling data allows the WHO to start its review right away to accelerate the overall review process

20 Jul 2021 10:49 AM

Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates

The price of each dose of Covishield amounts to Rs 215.25 and Covaxin Rs 225.75, including taxes

17 Jul 2021 12:53 PM

Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech

The indigenous vaccine showed 63.6 per cent efficacy against the Delta variant of Covid-19

13 Jul 2021 8:36 AM

Decision on emergency use listing of Covaxin likely in 4-6 weeks: WHO

Swaminathan said WHO is reviewing Covaxin as its manufacturer Bharat Biotech is now uploading its entire data on the health body's portal

10 Jul 2021 5:01 PM

Final analysis of Covaxin efficacy out; 65.2 per cent effective against Delta

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptomatic COVID-19 cases

03 Jul 2021 10:50 AM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT